Durham Peptides' test reports are typically dated within weeks of the batch production, giving buyers confidence in the freshness of the product
Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results
This combination is not typically paired with retatrutide, which overlaps on the same receptors and adds redundant signaling and side-effect risk
TB-500, by contrast, distributes systemically
Magnesium is involved in hundreds of enzymatic reactions including those that regulate calcium metabolism and bone mineral density
The peptide maintains endothelial integrity to ensure proper blood flow to the mucosa while directly stimulating cellular repair processes